ENSIGN GROUP, INC·4

Feb 20, 5:03 PM ET

Wittekind Beverly B. 4

4 · ENSIGN GROUP, INC · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Ensign Group (ENSG) VP/CLO Beverly Wittekind Sells Shares After Exercise

What Happened
Beverly B. Wittekind, Vice President and Chief Legal Officer of Ensign Group (ENSG), exercised equity and had restricted shares vest on Feb 19, 2026, then sold shares into the open market. Transactions reported: she exercised 500 option-derived shares at $83.64 each (cost $41,820), sold 500 shares on the open market at $210.23 for $105,115, and had 113 shares withheld to satisfy tax withholding related to a restricted-stock net settlement (treated as a disposition valued at $23,140). In addition, 500 restricted shares were converted/vested (derivative conversion at $0). The open-market sale was executed under a prearranged Rule 10b5-1 trading plan.

Key Details

  • Transaction date: 2026-02-19 (reported on Form 4 filed 2026-02-20).
  • Option exercise: 500 shares acquired at $83.64 each — total cost $41,820.
  • Open-market sale: 500 shares sold at $210.23 each — proceeds $105,115 (per footnote, executed under a 10b5-1 plan adopted 9/2/2025).
  • Tax withholding: 113 shares withheld at $204.78 each to satisfy tax obligations — value $23,140 (these withheld shares are not treated as a sale by the reporting person).
  • Restricted stock conversion: 500 shares converted/vested (listed as derivative conversion at $0); these were grants from 2/19/2021 that vest over five annual installments.
  • Shares owned after the transactions: not specified in the filing.
  • Filing timeliness: filing was made the next day; no late filing flag indicated.

Context
This sequence is typical of compensation-related activity: options exercised and restricted shares vested, with a portion sold and a portion withheld for taxes. The immediate open-market sale was executed under a 10b5-1 plan (prearranged), which generally indicates the sale was preplanned rather than a discretionary trade. Such transactions are routine and reflect compensation monetization rather than an explicit endorsement or rejection of company prospects.

Insider Transaction Report

Form 4
Period: 2026-02-19
Wittekind Beverly B.
VP and Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-19$83.64/sh+500$41,82033,279 total
  • Sale

    Common Stock

    [F1]
    2026-02-19$210.23/sh500$105,11532,779 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-19$204.78/sh113$23,14032,666 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F1][F3]
    2026-02-195000 total
    Exercise: $83.64From: 2022-02-19Exp: 2031-02-19Common Stock (500 underlying)
Footnotes (3)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
  • [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale by the Reporting Person. The shares were originally granted on February 19, 2021 and vested in five equal installments beginning February 19, 2022.
  • [F3]These shares were granted February 19, 2021 and vested over 5 equal annual installments.
Signature
/s/ Chad A. Keetch, as power of attorney|2026-02-20

Documents

1 file
  • 4
    wk-form4_1771624998.xmlPrimary

    FORM 4